Perbedaan Indo Pureco Pratama Tbk. dan UBC Medical Indonesia Tbk.: Indo Pureco Pratama Tbk. diperdagangkan di Rp14 (kapitalisasi pasar 64,4 M), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp174 (kapitalisasi pasar 691,25 M, volume 24 jam 635,5 rb). Perbedaan utamanya: UBC Medical Indonesia Tbk. jauh lebih besar — sekitar 10,7× kapitalisasi pasar Indo Pureco Pratama Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| IPPE | LABS | |
|---|---|---|
Kapitalisasi Pasar | 64,4 M | 691,25 M |
Volume | — | 635,5 rb |
Lot | — | 6,36 rb |
Perputaran | — | 110,15 jt |
Harga Rata-rata | — | 173,33 |
Nilai Transaksi | — | 110,15 jt |
Harga Ekuilibrium Indikatif | — | 174 |
Volume Ekuilibrium Indikatif | — | 50 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Indo Pureco Pratama Tbk ("the Company") was established based on Notarial Deed No. 839 dated March 20, 2019, by Joice Hapsari Fendrini, S.H., M.Kn., Notary in Subang. The Company started its commercial operations in March 2019. The Company has coconut flesh processing factory located at Balimbing, Sub-District Pagaden Barat, District Subang, West Java, Indonesia.
Selengkapnya di halaman IPPE →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →